1.
Embryonic stem cell trials for macular degeneration: a preliminary report
by Schwartz, Steven D, Prof
The Lancet (British edition), 2012, Vol.379 (9817), p.713-720
2.
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
by Thiele, Holger, Prof
The Lancet (British edition), 2013, Vol.382 (9905), p.1638-1645
3.
Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial
by Heidegger, Claudia Paula, MD
The Lancet (British edition), 2013, Vol.381 (9864), p.385-393
4.
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions
by Latouche, Aurelien
Journal of clinical epidemiology, 2013, Vol.66 (6), p.648-653
5.
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV...
by BOUTIN, Sylvie
Human gene therapy, 2010, Vol.21 (6), p.704-712
6.
Towards regenerative therapy for cardiac disease
by Ptaszek, Leon M, MD
The Lancet (British edition), 2012, Vol.379 (9819), p.933-942
7.
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector : Short-Term Results of a Phase I Trial
by HAUSWIRTH, William W
Human gene therapy, 2008, Vol.19 (10), p.979-990
8.
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)
by Dohan Ehrenfest, David M
Trends in biotechnology (Regular ed.), 2008, Vol.27 (3), p.158-167
9.
Adult mice generated from induced pluripotent stem cells
by Nazor, Kristopher L
Nature (London), 2009, Vol.461 (7260), p.91-94
10.
The Regulation of Differentiation in Mesenchymal Stem Cells
by AUGELLO, Andrea
Human gene therapy, 2010, Vol.21 (10), p.1226-1238
11.
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
by Morgan, Richard A.
Human gene therapy, 2012, Vol.23 (10), p.143-1053
12.
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
by Mittermeyer, Gabriele
Human gene therapy, 2012, Vol.23 (4), p.377-381
13.
Bone Marrow Mesenchymal Stem Cells: Historical Overview and Concepts
by CHARBORD, Pierre
Human gene therapy, 2010, Vol.21 (9), p.1045-1056
14.
Consensus Statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: Characteristics Recommended for the Identification and Document...
by White, Jane V., PhD, RD, FADA
Journal of the Academy of Nutrition and Dietetics, 2012, Vol.112 (5), p.730-738
15.
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
by Ambati, Jayakrishna
Nature, 2008, Vol.452 (7187), p.591-597
16.
Generation of pluripotent stem cells from adult human testis
by Skutella, Thomas
Nature, 2008, Vol.456 (7220), p.344-349
17.
Elite and stochastic models for induced pluripotent stem cell generation
by Yamanaka, Shinya
Nature (London), 2009, Vol.460 (7251), p.49-52
18.
Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)
by Ronco, Claudio, Dr
The Lancet (British edition), 2014, Vol.383 (9931), p.1807-1813
19.
Producing primate embryonic stem cells by somatic cell nuclear transfer
by BYRNE, J. A
Nature, 2007, Vol.450 (7169), p.497-502
20.
A protein interaction network for pluripotency of embryonic stem cells
by Levasseur, Dana N
Nature, 2006, Vol.444 (7117), p.364-368
